These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10886138)

  • 1. Hexafluoro-1,25-dihydroxyvitamin D3 has markedly increased potency in inhibiting proliferation of cultured human keratinocytes compared with 1,25-dihydroxyvitamin D3.
    Chen TC; Holick MF
    Br J Dermatol; 2000 Jul; 143(1):72-8. PubMed ID: 10886138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer.
    Chen TC; Holick MF; Lokeshwar BL; Burnstein KL; Schwartz GG
    Recent Results Cancer Res; 2003; 164():273-88. PubMed ID: 12899529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similarly potent action of 1,25-dihydroxyvitamin D3 and its analogues, tacalcitol, calcipotriol, and maxacalcitol on normal human keratinocyte proliferation and differentiation.
    Takahashi H; Ibe M; Kinouchi M; Ishida-Yamamoto A; Hashimoto Y; Iizuka H
    J Dermatol Sci; 2003 Feb; 31(1):21-8. PubMed ID: 12615360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased biological potency of hexafluorinated analogs of 1,25-dihydroxyvitamin D3 on bovine parathyroid cells.
    Imanishi Y; Inaba M; Seki H; Koyama H; Nishizawa Y; Morii H; Otani S
    J Steroid Biochem Mol Biol; 1999; 70(4-6):243-8. PubMed ID: 10622414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 26,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 1 alpha,25-dihydroxyvitamin D3 on the resorption of bone explants ex vivo.
    Miyahara T; Harada M; Kozakai A; Matsumoto M; Hashimoto K; Inoue H; Yoda K; Nakatsu T; Kajita S; Yamazaki R; Higuchi S; Kozuka H; Nemoto N
    J Nutr Sci Vitaminol (Tokyo); 1999 Jun; 45(3):239-49. PubMed ID: 10524344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects on cultured neonatal mouse calvaria of 1 alpha,25-dihydroxyvitamin D3, 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 26,26,26,27,27,27-hexafluoro-1 alpha,23S,25-trihydroxyvitamin D3.
    Harada M; Miyahara T; Miyata M; Tomita I; Okayachi H; Ikemoto Y; Higuchi S; Otomo S; Kozuka H; Ikekawa N
    Bone Miner; 1992 Jul; 18(1):41-9. PubMed ID: 1422297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells.
    Miyahara T; Simoura T; Osahune N; Uchida Y; Sakuma T; Nemoto N; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Chiba H; Iba K; Sawada N
    Calcif Tissue Int; 2002 Jun; 70(6):488-95. PubMed ID: 12016462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation and differentiation of cultured human keratinocytes is modulated by 1,25(OH)2D3 and synthetic vitamin D3 analogues in a cell density-, calcium- and serum-dependent manner.
    Svendsen ML; Daneels G; Geysen J; Binderup L; Kragballe K
    Pharmacol Toxicol; 1997 Jan; 80(1):49-56. PubMed ID: 9148283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a highly potent fluoro analog of 1,25-dihydroxyvitamin D3 on human bone-derived cells.
    Kiriyama T; Okamoto S; Ejima E; Kurihara N; Hakeda Y; Ito N; Izumi M; Kumegawa M; Nagataki S
    Endocrinology; 1991 Jan; 128(1):81-6. PubMed ID: 1846118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activities of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 on human promyelocytic leukemic HL-60 cells: effects of fetal bovine serum and of incubation time.
    Okuno S; Inaba M; Nishizawa Y; Morii H
    Miner Electrolyte Metab; 1995; 21(1-3):211-6. PubMed ID: 7565452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 1,24R-dihydroxyvitamin D3 on the growth of human keratinocytes.
    Matsumoto K; Hashimoto K; Kiyoki M; Yamamoto M; Yoshikawa K
    J Dermatol; 1990 Feb; 17(2):97-103. PubMed ID: 2158504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines.
    Gniadecki R
    Br J Pharmacol; 1997 Mar; 120(6):1119-27. PubMed ID: 9134225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for use and clinical responsiveness of hexafluoro-1,25-dihydroxyvitamin D3 for the treatment of plaque psoriasis: a pilot study.
    Durakovic C; Malabanan A; Holick MF
    Br J Dermatol; 2001 Mar; 144(3):500-6. PubMed ID: 11260006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hexafluoro-1,25-dihydroxyvitamin D3 and sodium butyrate combination on differentiation and proliferation of HL-60 leukemia cells.
    Yoshida M; Tanaka Y; Eguchi T; Ikekawa N; Saijo N
    Anticancer Res; 1992; 12(6B):1947-52. PubMed ID: 1363510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA binding property of vitamin D3 receptors associated with 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3.
    Inaba M; Okuno S; Inoue A; Nishizawa Y; Morii H; DeLuca HF
    Arch Biochem Biophys; 1989 Jan; 268(1):35-9. PubMed ID: 2463789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1 alpha,24R-dihydroxyvitamin D3 has an ability comparable to that of 1 alpha,25-dihydroxyvitamin D3 to induce keratinocyte differentiation.
    Kobayashi T; Okumura H; Azuma Y; Kiyoki M; Matsumoto K; Hashimoto K; Yoshikawa K
    J Dermatol; 1990 Nov; 17(11):707-9. PubMed ID: 2094749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of 26,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 26,27-hexafluoro-1 alpha,23(S)25-trihydroxyvitamin D3 in ROS17/2.8 cells transfected with a plasmid expressing CYP24.
    Miyahara T; Gomyo S; Ueda Y; Ohyama Y; Sigeno C; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Yamamoto M; Sakuma T; Nemoto N
    Xenobiotica; 2000 Nov; 30(11):1055-62. PubMed ID: 11197067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antiproliferative and differentiative activities of 1,25-dihydroxyvitamin D3 are potentiated by epidermal growth factor and attenuated by insulin in cultured human keratinocytes.
    Chen TC; Persons K; Liu WW; Chen ML; Holick MF
    J Invest Dermatol; 1995 Jan; 104(1):113-7. PubMed ID: 7798628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth-inhibitory effects of 1,25-dihydroxyvitamin D3 on normal and psoriatic keratinocytes.
    Hashimoto K; Matsumoto K; Higashiyama M; Nishida Y; Yoshikawa K
    Br J Dermatol; 1990 Jul; 123(1):93-8. PubMed ID: 2390499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of 1 alpha,25-dihydroxyvitamin D3 metabolism by introduction of 26,26,26,27,27,27-hexafluoro atoms in human promyelocytic leukaemia (HL-60) cells: isolation and identification of a novel bioactive metabolite, 26,26,26,27,27,27-hexafluoro-1 alpha,23(S),25-trihydroxyvitamin D3.
    Honda A; Nakashima N; Shida Y; Mori Y; Nagata A; Ishizuka S
    Biochem J; 1993 Oct; 295 ( Pt 2)(Pt 2):509-16. PubMed ID: 8240250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.